A novel simplified structural design as an artificial enzyme for efficient hydrolysis of PNPA

A novel simplified structural design as an artificial enzyme for efficient hydrolysis of PNPA

Results

Eevaluation of catalytic efficacy of Zn(II)-SMM

p-nitrophenyl acetate (PNPA) was selected as a typical substrate for the evaluation of catalytic efficacy of Zn(II)-SMM. Notably, the slope of reaction rates increased significantly with rising concentrations of PNPA from 20 µM to 100 µM compared to spontaneous reactions under identical conditionsFig. . 2b and Figure S3), indicating that Zn(II)-SMM exhibited unexpectedly high activity for hydrolysis of PNPA hydrolysis in mixtures of HEPES-DMSO and an incremental rate of hydrolysis.

Fig. 2
A novel simplified structural design as an artificial enzyme for efficient hydrolysis of PNPA

(a) The hydrolysis reaction for the substrate p-nitrophenyl acetate (PNPA). (b) Plots of absorbance vs. time at 400 nm in HEPES of different concentrations for substrate PNPA assisted by 10 µM Zn(II)-SMM in a DMSO/ H EPES mixture (20 : 80 v/v) at 25 ◦C and pH 7.0, Blank: DMSO / HEPES mixture (20 : 80 v/v) at 25 ◦C and pH 7.0 .

Full size image

Even upon introducing tenfold excess substrate amounts, catalytic hydrolysis consistently concluded within approximately sixty seconds—highlighting the remarkably high catalytic efficiency of this enzyme system (Fig. 2). The apparent rate constant Kobs was determined by varying concentrations of Zn2+ (Fig. 3), Kobs gradually increased until reaching a molar ratio of Zn2+ to SMM at 1:1—suggesting that the hydrolase complex Zn(II)-SMM comprised one mole each of Zn2+ and SMM.

Fig. 3
figure 3

Plots of Kobs for the hydrolysis of PNPA (50 µM) by Zn(II)-SMM (10 µM) in DMSO/HEPES mixture (20 : 80 v/v) with the increase concentration of Zn2+ at 25 ◦C and pH 7.0.

Full size image

Computational insights

To elucidate the binding mechanism of SMM with Zn2+, energy simulation calculations were conducted. The energy simulations reveal that Zn2+ adopts a characteristic planar structure involving acyl oxygen and nitrogen atoms, achieving maximum stability in a tetrahedral configuration with the nitrogen atom on pyridine Fig.  1). This configuration is energetically favored by 99.62 kJ/mol compared to alkyl-oxygen coordination (Figure S2), utilizing the b3lyp/6–31 g(d, p) method via Gaussian software.

UV-vis monitoring for catalytic effects

The primary architecture of the hydrolase was engineered using a quinoline derivative, facilitating the proximity of PNPA with analogous organic structure and interaction with metal ions. In this study, the hydrolysis of PNPA yielded phenol, which exhibited UV absorption at 400 nm29. To gain deeper insights into the catalytic effect, UV monitoring experiments were conducted (Figure S1). The results indicated that phenol concentration increased over time; however, no hydrolysis occurred with the removal of SMM (Figure S3), implying that Zn(II)-SMM could associate with the substrate and promote the hydrolysis of it.

Kinetics

The kinetics of catalytic hydrolysis of Zn(II)-SMM on PNPA were investigated in detail to elucidate the behavior of the catalytic hydrolysis. The experimental findings showed a characteristic double reciprocal plot and saturation kinetics curve (Figure S4), confirming that the catalytic activity adheres to the Michaelis-Menten Eq. 30, thereby indicating enzyme-like characteristics of the Zn(II)-SMM complex. The calculated kinetic parameter value was 0.8287 min-1 (Kcat), and the hydrolysis rate is 5239 times greater than that of the spontaneous reaction.

Mechanism and pathway

The hydrolysis rate constant of Zn(II)-SMM system was evaluated across various pH levels, and the results (Figure S5) indicated that following the activation of Lewis acid within the system, the monohydroxyl form of the metal ion complex acted as an effective catalyst for.

Fig. 4
figure 4

(a) Mechanism of PNPA hydrolysis catalyzed by SMM. (b) Schematic representation of the hydrolysis mechanism for PNPA.

Full size image

PNPA hydrolysis. Under acidic conditions, the pyridine moiety of the Zn(II)-SMM complex readily.

associates with H+, hindering substrate access and resulting in infrequent hydrolysis events. Conversely, as pH increased, deprotonation of the Zn(II)-SMM complex allowed water to coordinate with Zn2+,

forming a Zn-OH bond that facilitates nucleophilic attack on PNPA, thereby accelerating its hydrolysis.

The proposed hydrolysis mechanism of PNPA under neutral conditions is also illustrated in Fig. 4. Here, the catalytic site of Zn-OH functions as either a general base or nucleophile to activate the C-O carbonyl bond and generate a transition state conducive to cleavage of this bond and subsequent release of p-nitrophenol, the mechanism is hypothesized to align with that of single Lewis acid activation31,32,33.

Discussion

A novel small molecular organic complex capable of coordinating with Zn2+ has been designed, which effectively binds and catalyzes the hydrolysis of the substrate PNPA. This system has been proved to own the ability to mimic the catalytic hydrolysis function of metal hydrolases, and the catalytic rate (kcat/kuncat) exceeds 5239 times that of non-catalytic systems. Furthermore, saturation kinetics studies indicate that the catalytic process of the Zn(II)-SMM complex adheres to the Michaelis-Menten equation, identical to natural enzymes. The hydrolysis mechanism employed by this engineered metal hydrolase is characterized as a single Lewis acid activation. The results of this work elucidates that the artificial metal hydrolase Zn(II)-SMM system is a promising candidate for the design of small molecule hydrolases, and it is believed that this facile route to construct metal hydrolases provides a convenient path for catalytic research, most importantly, it lays the foundation for the further pursuit of our research on chiral metallohydrolase.

Methods

Materials and physical measurements

All chemicals including o-toluidine, bis (pyridin-2-ylmethyl) amine etc. and solvents were of pure analytical grade and obtained commercially from aladdin company. The synthesized small molecule-based metallohydrolase (SMM) prepared via organic synthesis method were characterized through 1 H NMR, 13 C NMR, and MALDI-TOF-MS.

figure a

Synthesis of SMM compound and characterizations

Synthesis of compound 2

Compound 1(10 g, 36.6 mmol)), NBS (6.83 g, 38.4 mmol, 1.05 eq) and BPO (9.3 g, 38.4 mmol, 1.05 eq) were dissolved in 100 mL of benzene at 80 °C. The mixture was refluxed for 6 h. the organic solvent was then removed under reduced pressure, the residue was washed with dichloromethane and water. The product was purified by column chromatography with 200–300 mesh silica gel column. The collected product was dried under reduced pressure to give a white solid (9.8 g, 76% yield).

Synthesis of compound 3

Compound 2 (700 mg, 2.06 mmol), 2,2’ -dimethylpyridinolamine (0.82 g, 4.12 mmol), potassium carbonate (1.13 g, 8.23 mmol), Anhydrous DMF(10 mL) was mixed and stirred for 1.5 h, then diluted with 1 M HCl, and washed with AcOEt, the organic phase was dried with MgSO4, and the solvent was removed in vacuum, the target compound 3 (773 mg, 65% yield) was purified by column chromatography ( silica gel, CHCl3/ MeOH ).

Related Articles

Energy metabolism in health and diseases

Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This review provides an extensive overview of advancements in energy metabolism research, elucidating critical pathways such as glycolysis, oxidative phosphorylation, fatty acid metabolism, and amino acid metabolism, along with their intricate regulatory mechanisms. The homeostatic balance of these processes is crucial; however, in pathological states such as neurodegenerative diseases, autoimmune disorders, and cancer, extensive metabolic reprogramming occurs, resulting in impaired glucose metabolism and mitochondrial dysfunction, which accelerate disease progression. Recent investigations into key regulatory pathways, including mechanistic target of rapamycin, sirtuins, and adenosine monophosphate-activated protein kinase, have considerably deepened our understanding of metabolic dysregulation and opened new avenues for therapeutic innovation. Emerging technologies, such as fluorescent probes, nano-biomaterials, and metabolomic analyses, promise substantial improvements in diagnostic precision. This review critically examines recent advancements and ongoing challenges in metabolism research, emphasizing its potential for precision diagnostics and personalized therapeutic interventions. Future studies should prioritize unraveling the regulatory mechanisms of energy metabolism and the dynamics of intercellular energy interactions. Integrating cutting-edge gene-editing technologies and multi-omics approaches, the development of multi-target pharmaceuticals in synergy with existing therapies such as immunotherapy and dietary interventions could enhance therapeutic efficacy. Personalized metabolic analysis is indispensable for crafting tailored treatment protocols, ultimately providing more accurate medical solutions for patients. This review aims to deepen the understanding and improve the application of energy metabolism to drive innovative diagnostic and therapeutic strategies.

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

Macrophages are immune cells belonging to the mononuclear phagocyte system. They play crucial roles in immune defense, surveillance, and homeostasis. This review systematically discusses the types of hematopoietic progenitors that give rise to macrophages, including primitive hematopoietic progenitors, erythro-myeloid progenitors, and hematopoietic stem cells. These progenitors have distinct genetic backgrounds and developmental processes. Accordingly, macrophages exhibit complex and diverse functions in the body, including phagocytosis and clearance of cellular debris, antigen presentation, and immune response, regulation of inflammation and cytokine production, tissue remodeling and repair, and multi-level regulatory signaling pathways/crosstalk involved in homeostasis and physiology. Besides, tumor-associated macrophages are a key component of the TME, exhibiting both anti-tumor and pro-tumor properties. Furthermore, the functional status of macrophages is closely linked to the development of various diseases, including cancer, autoimmune disorders, cardiovascular disease, neurodegenerative diseases, metabolic conditions, and trauma. Targeting macrophages has emerged as a promising therapeutic strategy in these contexts. Clinical trials of macrophage-based targeted drugs, macrophage-based immunotherapies, and nanoparticle-based therapy were comprehensively summarized. Potential challenges and future directions in targeting macrophages have also been discussed. Overall, our review highlights the significance of this versatile immune cell in human health and disease, which is expected to inform future research and clinical practice.

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines. The integration of novel drug design and synthesis techniques, display library technology, delivery systems, bioengineering advancements, and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs, effectively addressing the obstacles associated with their character, such as the rapid clearance and degradation, necessitating subcutaneous injection leading to increasing patient discomfort, and ultimately advancing translational research efforts. Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions, such as diabetes mellitus, weight loss, oncology, and rare diseases, and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines. This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics, delivery platforms, and vaccines. It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs, as well as the recent advancements in screening, design, and delivery technologies. The accelerated advancement in the development of novel peptide-based therapeutics, including peptide-drug complexes, new peptide-based vaccines, and innovative peptide-based diagnostic reagents, has the potential to promote the era of precise customization of disease therapeutic schedule.

Advances in the structures, mechanisms and targeting of molecular chaperones

Molecular chaperones, a class of complex client regulatory systems, play significant roles in the prevention of protein misfolding and abnormal aggregation, the modulation of protein homeostasis, and the protection of cells from damage under constantly changing environmental conditions. As the understanding of the biological mechanisms of molecular chaperones has increased, their link with the occurrence and progression of disease has suggested that these proteins are promising targets for therapeutic intervention, drawing intensive interest. Here, we review recent advances in determining the structures of molecular chaperones and heat shock protein 90 (HSP90) chaperone system complexes. We also describe the features of molecular chaperones and shed light on the complicated regulatory mechanism that operates through interactions with various co-chaperones in molecular chaperone cycles. In addition, how molecular chaperones affect diseases by regulating pathogenic proteins has been thoroughly analyzed. Furthermore, we focus on molecular chaperones to systematically discuss recent clinical advances and various drug design strategies in the preclinical stage. Recent studies have identified a variety of novel regulatory strategies targeting molecular chaperone systems with compounds that act through different mechanisms from those of traditional inhibitors. Therefore, as more novel design strategies are developed, targeting molecular chaperones will significantly contribute to the discovery of new potential drugs.

Photovoltaic bioelectronics merging biology with new generation semiconductors and light in biophotovoltaics photobiomodulation and biosensing

This review covers advancements in biosensing, biophotovoltaics, and photobiomodulation, focusing on the synergistic use of light, biomaterials, cells or tissues, interfaced with photosensitive dye-sensitized, perovskite, and conjugated polymer organic semiconductors or nanoparticles. Integration of semiconductor and biological systems, using non-invasive light-probes or -stimuli for both sensing and controlling biological behavior, has led to groundbreaking applications like artificial retinas. From fusion of photovoltaics and biology, a new research field emerges: photovoltaic bioelectronics.

Responses

Your email address will not be published. Required fields are marked *